These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27928909)

  • 1. Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Proteomics; 2017 Jan; 17(1-2):. PubMed ID: 27928909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
    Jorgačević B; Vučević D; Vesković M; Mladenović D; Vukićević D; Vukićević RJ; Todorović V; Radosavljević T
    Can J Physiol Pharmacol; 2019 Feb; 97(2):120-129. PubMed ID: 30673308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB
    Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
    Elife; 2020 Nov; 9():. PubMed ID: 33210603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Biochem Biophys Res Commun; 2015 May; 460(4):1063-8. PubMed ID: 25843798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice.
    Chen B; Hu N
    Braz J Med Biol Res; 2017 May; 50(6):e6141. PubMed ID: 28492810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease.
    Jorgačević B; Vučević D; Đuričić I; Šobajić S; Mladenović D; Vesković M; Vukićević RJ; Radosavljević T
    Chem Phys Lipids; 2017 Apr; 204():85-93. PubMed ID: 28363784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice.
    Bahirat UA; Shenoy RR; Goel RN; Nemmani KV
    Eur J Pharmacol; 2017 Apr; 801():35-45. PubMed ID: 28274625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
    Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
    J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
    Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
    Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
    Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.
    Sathyapalan T; Dakroury Y; Ahmed L; Elshewehy AM; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):671-3. PubMed ID: 27256522
    [No Abstract]   [Full Text] [Related]  

  • 17. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
    Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
    J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Profiling of CB1 Neutral Antagonists.
    Seltzman HH; Maitra R; Bortoff K; Henson J; Reggio PH; Wesley D; Tam J
    Methods Enzymol; 2017; 593():199-215. PubMed ID: 28750803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models.
    Kawata Y; Okuda S; Hotta N; Igawa H; Takahashi M; Ikoma M; Kasai S; Ando A; Satomi Y; Nishida M; Nakayama M; Yamamoto S; Nagisa Y; Takekawa S
    Eur J Pharmacol; 2017 Feb; 796():45-53. PubMed ID: 27986627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
    Choi RY; Ham JR; Lee MK
    Chem Biol Interact; 2016 Dec; 260():13-21. PubMed ID: 27769711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.